Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

June 15, 2023; Volume 20,Issue 6

Review

  • You have access
    Therapeutic implications of cancer stem cells in prostate cancer
    Pinaki Banerjee, Prachi Kapse, Shehnaz Siddique, Moumita Kundu, Jasoda Choudhari, Varshasnata Mohanty, Diksha Malhotra, Suresh W. Gosavi, Rajesh N. Gacche and Gopal C. Kundu
    Cancer Biology & Medicine June 2023, 20 (6) 401-420; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0714

Original Articles

  • You have access
    Neutrophils as key regulators of tumor immunity that restrict immune checkpoint blockade in liver cancer
    Mei Feng, Fangyanni Wang, Xinyu Liu, Tingting Hao, Ning Zhang, Mi Deng, Yisheng Pan and Ruirui Kong
    Cancer Biology & Medicine June 2023, 20 (6) 421-437; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0019
  • You have access
    Associations between polymorphisms in leptin and leptin receptor genes and colorectal cancer survival
    Meizhi Du, Yu Wang, Jillian Vallis, Matin Shariati, Patrick S. Parfrey, John R. Mclaughlin, Peizhong Peter Wang and Yun Zhu
    Cancer Biology & Medicine June 2023, 20 (6) 438-451; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0635
  • You have access
    Simultaneous integrated dose reduction intensity-modulated radiotherapy effectively reduces cardiac toxicity in limited-stage small cell lung cancer
    Jing Luo, Jiawei Song, Li Xiao, Jiajia Zhang, Yipeng Cao, Jun Wang, Ping Wang, Lujun Zhao and Ningbo Liu
    Cancer Biology & Medicine June 2023, 20 (6) 452-464; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0326
  • You have access
    Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up
    Zhuang Kang, Shan Li, Xun Kang, Jing Deng, Huarong Yang, Feng Chen, Jiandong Jiang, Jie Zhang and Wenbin Li
    Cancer Biology & Medicine June 2023, 20 (6) 465-476; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0762
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 20 (6)
Cancer Biology & Medicine
Vol. 20, Issue 6
15 Jun 2023
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Review
  • Original Articles

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire